Market Tracker

04/29 5:16pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

10.55
Delayed Data
As of Apr 29
 -0.29 / -2.68%
Today’s Change
6.96
Today|||52-Week Range
25.25
-39.12%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close10.84
Today’s open10.79
Day’s range10.47 - 10.98
Volume1,238,634
Average volume (3 months)1,814,853
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+55.36%
Earnings growth (this year)-286.27%
Earnings growth (next 5 years)--
Revenue growth (last year)+79.28%
P/E ratioNM
Price/Sales16.26
Price/Book32.31

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...-0.23-0.48%
NVAXNovavax Inc-0.21-3.85%
AXONAxovant Sciences Ltd-0.13-0.99%
RDUSRadius Health Inc-0.93-2.55%
Data as of 4:04pm ET, 04/29/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$135.1M
Annual profit (last year)-$32.2M
Net profit margin-23.86%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts